series-b
Stage
2017
Founded
1
Investors
About
BostonGene is a biomedical software company that has developed an AI-driven molecular and immune profiling platform to identify and validate novel targets for personalized cancer therapies.
Explore BostonGene's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.